Using M&S to Evaluate Oncology Drug Dosing Blog Using M&S to Evaluate Oncology Drug Dosing There are numerous challenges in developing oncology drugs: (1) they are often very toxic which…CertaraApril 13, 2018
Population Pharmacokinetics of Intravenous Linezolid in Premature Infants Publication Population Pharmacokinetics of Intravenous Linezolid in Premature Infants CertaraApril 9, 2018
Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations Publication Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations CertaraApril 1, 2018
An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Publication An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) CertaraMarch 15, 2018
Using Virtual Twin Technology to Predict Drug Exposure in Individual Patients On-Demand Webinar Using Virtual Twin Technology to Predict Drug Exposure in Individual Patients In this webinar, Dr. Tom Polasek, a clinical pharmacologist at Certara Strategic Consulting, explained how…CertaraMarch 8, 2018
Skin in the Game: Mechanistic Modeling of Dermal Drug Absorption Blog Skin in the Game: Mechanistic Modeling of Dermal Drug Absorption The ability to estimate systemic exposure from dermal absorption is essential in developing new dermatological…CertaraMarch 2, 2018
A Randomized, Controlled Trial Evaluating the Efficacy and Safety of BTH1677 in Combination with Bevacizumab, Carboplatin, and Paclitaxel in First-line Treatment of Advanced Non-small Cell Lung Cancer Publication A Randomized, Controlled Trial Evaluating the Efficacy and Safety of BTH1677 in Combination with Bevacizumab, Carboplatin, and Paclitaxel in First-line Treatment of Advanced Non-small Cell Lung Cancer CertaraFebruary 27, 2018
Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation Publication Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation CertaraFebruary 22, 2018
Surveying the Lay of the Land for Modeling & Simulation for Global Regulatory Submissions Blog Surveying the Lay of the Land for Modeling & Simulation for Global Regulatory Submissions Analogous to how a geologist surveys the “lay of the land” to determine if oil…CertaraFebruary 16, 2018
Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor Publication Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor CertaraFebruary 15, 2018